MD - MEDNAX, Inc.

NYSE - NYSE Delayed Price. Currency in USD

Cash Flow

Annual
All numbers in thousands
Period Ending12/31/201812/31/201712/31/201612/31/2015
Net Income268,629320,372324,914336,320
Operating Activities, Cash Flows Provided By or Used In
Depreciation111,281102,87989,26464,228
Adjustments To Net Income8,223-28,76956,85946,483
Changes In Accounts Receivables-36,5987,803-34,000-55,391
Changes In Liabilities15,39024,55111,617-7,874
Changes In Inventories----
Changes In Other Operating Activities-15,74411,492-2,642-10,964
Total Cash Flow From Operating Activities289,925511,378443,778368,701
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditure-48,868-49,309-39,264-27,073
Investments-2,174-2,313-19,651-2,024
Other Cash flows from Investing Activities-6,7056,7056,705
Total Cash Flows From Investing Activities-142,769-576,613-821,217-848,000
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid----
Sale Purchase of Stock----
Net Borrowings127,644144,733427,870713,329
Other Cash Flows from Financing Activities-12,353-8,080-6,499-15,463
Total Cash Flows From Financing Activities-170,61189,737381,565482,943
Effect Of Exchange Rate Changes----
Change In Cash and Cash Equivalents-23,45524,5024,1263,644